Statins have been vital in preventing heart disease by lowering cholesterol, but muscle pain and weakness remain common complaints. Now, scientists at the University of British Columbia have discovered exactly how these medications disrupt muscle function, revealing a pathway to design statins with fewer side effects.
- Statins disrupt calcium regulation in muscles, causing pain.
- Researchers pinpoint three statin molecules binding a key muscle protein.
- Findings may lead to statins with fewer muscle-related side effects.
What happened
In this groundbreaking study, scientists at the University of British Columbia collaborated with colleagues at the University of Wisconsin-Madison to investigate how statins affect muscle cells. They employed cryo-electron microscopy to examine the ryanodine receptor (RyR1), a protein that controls calcium flow crucial for muscle contraction. The research uncovered that statins cause this channel to remain open, leading to continuous calcium leakage.
This unregulated calcium flow can damage muscle tissue, explaining why some patients experience muscle pain, weakness, or in rare cases, more severe muscle injury. By focusing specifically on atorvastatin, a widely prescribed statin, the team showed that three statin molecules collectively bind inside a particular pocket of the calcium channel, causing it to leak.
Why it feels good
This discovery answers a longstanding question about how statins may cause muscle discomfort, which has often led patients to discontinue treatment despite its cardiovascular benefits. Understanding the molecular interaction provides clarity on the underlying cause rather than relying on symptoms alone.
The detailed structural insights create a roadmap for drug designers to modify statin molecules so they retain cholesterol-lowering power without disrupting muscle proteins. For millions worldwide who depend on statins, this represents a hopeful step toward more tolerable treatments that protect heart health while reducing unwanted side effects.
What to enjoy or watch next
Moving forward, researchers and pharmaceutical developers can use these findings to innovate new statin formulations or alternative therapies that avoid the problematic binding to muscle calcium channels. Such progress may improve adherence to cholesterol management regimens and reduce muscle-related complaints.
Meanwhile, patients taking statins should consult healthcare providers about muscle symptoms and discuss potential options. This study encourages ongoing research into personalized treatments that maximize benefits and minimize risks, enhancing quality of life for those managing cardiovascular health.